- Home
- Companies
- canada yukon
- disease development
Show results for
Refine by
Industries served
- Medical / Health Care
- Agriculture
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Manufacturing, Other
- Waste and Recycling
- Water and Wastewater
- Health and Safety
- University / Academia / Research
- Government
- Food and Beverage
- Energy
- Retail
- Commercial
- Pulp & Paper
- Real Estate
- Maritime/Shipbuild/Water Transport
- Oil, Gas & Refineries
- Environmental
- Soil and Groundwater
- Construction & Construction Materials
Disease Development Suppliers Serving Yukon
92 companies found
based inTel-Aviv, ISRAEL
RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of ...
RHB-104 is a potentially groundbreaking, proprietary investigational drug in oral capsule formulation, with potent intracellular, antimycobacterial and anti-inflammatory ...
based inGunpo-si, SOUTH KOREA
DxGen is Point-Of-Care (POC) diagnostics company. We provide products for entire stages of diabetes care from initial assessment to post-diagnosis treatment. Our goal is to help make clinical decisions in the care and treatment of patients at the ...
Test Kit is for in-vitro diagnostic (IVD) use to determine Glycated Albumin (GA) and Albumin quantitatively from serum or plasma. It is useful at initial assessment, the onset of therapy, and post-therapeutic monitoring of glycemic control. ...
based inSyracuse, NEW YORK (USA)
Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...
based inShenzhen, CHINA
LANDWIND MEDICAL is a health care group company headquartered in Shenzhen, China, established in 1994. Till now, we cater our global medical care to over 30,000 medical institutions in more than 130 countries. We integrate our dedicated and ...
Digital Color Doppler Diagnostic Ultrasound System Mirror5 Touch is designed with multiple applications to satisfy different users with varies needs on patient care. Confident in action, guaranteed by Landwind R&D team for performance with ...
based inRichmond, VIRGINIA (USA)
GLOBAL NUTRITECH is a privately owned company established in 2006 with the vision of using biotechnology research to address problems and inefficiencies in animal production. With offices in both the United States and Turkey, GLOBAL NUTRITECH® ...
based inLodi, ITALY
IBSA Farmaceutici, part of the Institute Biochimique SA Group, has its headquarter in Lodi, two manufacturing plants near Milan and three R&D labs which contribute to the Made in Italy’s success. More than 500 people are employed in Italy. IBSA ...
based inEdmonton, ALBERTA (CANADA)
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection. ...
based inCalgary, ALBERTA (CANADA)
Hemostemix (TSX V:HEM; OTCQB:HMTXF) is a clinical-stage biotechnology company focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. Hemostemix’s proprietary platform technology is based on more ...
Hemostemix’s technology uses a patient’s own cells to treat that patient’s disease. The cornerstone of this autologous technology is a novel cell population within the blood called the synergetic cell population ...
based inSan Jose, CALIFORNIA (USA)
LimFlow was founded with the deep belief that more could be done for the millions of patients worldwide suffering from the most severe form of peripheral artery disease — Chronic Limb-Threatening Ischemia (CLTI) — and who are facing the prospect of ...
based inEpalinges, SWITZERLAND
Novostia is a privately held medical device company developing an innovative artificial heart valve, especially for young patients. With the support of world leading surgeons, Novostia endeavors to improve the quality of life of millions of patients ...
based inVirum, DENMARK
Immudex was created in 2009 when it spun off from the diagnostic company Dako, now Agilent. Since then, Immudex has grown in numbers, employees, patents, product lines, partnerships, and customers served. Research, development, and commercial ...
A deeper understanding of viral-specific T-cell responses to COVID-19 is needed to explore vaccine responses, long-term immunity, predict patients at risk, and even prepare for the next pandemic. T-cell responses are believed to be important for ...
based inSpringdale, ARKANSAS (USA)
ImmunoVision is proud to be a member of the Erba Diagnostics family, a part of the global ERBA Mannheim Group. Earlier known by the name of IVAX Diagnostics, the company specializes in manufacture and marketing of proprietary diagnostic reagents, ...
The dsDNA antigen is a 2690 bp plasmid purified by alkaline lysis and chromatography. The purification process includes operations to minimize reactivity to antibodies against single-stranded DNA. Use of plasmid DNA in ELISA is an effective method ...
based inToronto, ONTARIO (CANADA)
20+ Years of Innovation! FUJIFILM VisualSonics designs and manufactures ultra high frequency in vivo imaging systems, for both research and clinical use. FUJIFILM VisualSonics specifically focuses on developing ultrasound technology that has been ...
based inSan Francisco, CALIFORNIA (USA)
Invitae’s mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Like wearing sunscreen or getting your blood pressure checked at the doctor, genetic testing is another important ...
Like wearing sunscreen or getting your blood pressure checked at the doctor, genetic testing is another important tool to help manage your health and lifestyle. Your genes can give you clues into your risk of developing ...
based inSunnyvale, CALIFORNIA (USA)
We are developing cellular and cell-derived therapeutics for the treatment of unmet cardiovascular and pulmonary diseases. Our Mission: To improve the lives of patients with cardiovascular and pulmonary diseases through the development of ...
based inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
based inNeedham, MASSACHUSETTS (USA)
Invicro is an integral part of the REALM IDx, Inc. group, which aims to accelerate personalized medicine, discover novel therapeutic targets and develop innovative therapeutic technologies for unmet medical needs. As a global research partner to the ...
Our diverse team of experts have experience in instrument engineering, signal processing, and pharmaceutical R&D, collectively resulting in a long history designing and executing imaging and pathology studies. Our scientists have performed ...
based inSeattle, WASHINGTON (USA)
Nexelis is your partner for assay and biomarker development, advanced bioanalytical and laboratory testing, and translational immunology. As the leading specialty laboratory, we have unrivaled expertise in immunology, specifically in the areas of ...
Selecting the appropriate in vivo model for your assays is critical for the success of your preclinical research program. At Nexelis, a Q² Solutions Company, we designed and developed disease specific in vivo ...
based inGhent/Zwijnaarde, BELGIUM
Confo Therapeutics’ unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. This technology platform combined with the pharmacologic ...
based inMiami, FLORIDA (USA)
We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Our lead investigational product is Lomecel-B, which is derived from culture-expanded medicinal signaling cells (MSCs) ...
We have an ongoing Phase 1 sub-study exploring whether Lomecel-B can improve the Metabolic Syndrome, and if the Metabolic Syndrome presents confounding issues for this treatment approach in Aging Frailty patients. This sub-study primarily focuses ...